SAVLON

This brand name is authorized in Ireland, Malta, Nigeria, New Zealand, United Kingdom, South Africa

Active ingredients

The drug SAVLON contains a combination of these active pharmaceutical ingredients (APIs):

1 Chlorhexidine UNII MOR84MUD8E - CHLORHEXIDINE GLUCONATE

Chlorhexidine is an antimicrobial agent, active against a broad spectrum of Gram-positive and Gram-negative organisms, yeasts, fungi, opportunistic anaerobes and aerobes. Chlorhexidine is mainly a “membrane-acting” agent that destroys the outer membrane of the bacteria. It is inactive on bacterial spores unless the temperatures are high. Read about Chlorhexidine

2 Cetrimide UNII 24QSH2NL8N - CETRIMIDE

Cetrimide is a quaternary ammonium cationic disinfectant with bactericidal activity against gram-positive and some gram-negative organisms. Cetrimide is relatively ineffective against viruses. Read about Cetrimide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SAVLON DRY Cutaneous spray, powder	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D08AC52	Chlorhexidine, combinations	D Dermatologicals → D08 Antiseptics and disinfectants → D08A Antiseptics and disinfectants → D08AC Biguanides and amidines
Discover more medicines within D08AC52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 37130, 37131, 37132, 37133
Country: MT	Medicines Authority	Identifier(s): AA1438/06301, AA908/26401
Country: NG	Registered Drug Product Database	Identifier(s): 04-1289
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1465
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/13.1/0445